Delivery Order SPE2DX22D0010-SPE2D825FHD20
- Not listed
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Concerta ER Tabs 27mg, a medication used to treat attention deficit hyperactivity disorder. This firm fixed price delivery order, valued at $34,825.79, represents a non-set-aside competitive award and is scheduled for completion by July 31, 2025. The contract will be fulfilled from AmerisourceBergen's corporate offices in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency Medical Supply Chain awarded a $21,395.38 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Concerta ER Tabs 36mg, a controlled-release methylphenidate medication used to treat attention-deficit/hyperactivity disorder. The contract is a firm fixed price delivery order with an ultimate completion date of July 21, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This award was competitively awarded...
- The U.S. Defense Department's Medical Supply Chain awarded a $45,744.59 delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Concerta ER Tabs 36mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This non-set-aside, competitively awarded contract employs firm fixed pricing and is classified as a delivery order under a larger indefinite delivery contract vehicle. Performance will be executed from...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Concerta ER Tabs 27mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $8,217.60 with an ultimate completion date of August 12, 2025, was competitively awarded without set-aside designation. The contract will be performed at AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Concerta ER Tablets 36mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $67,832.46, represents a competitively awarded, non-set-aside contract with an ultimate completion date of August 28, 2025. AmerisourceBergen Drug Corp, headquartered in...
- The U.S. Defense Department's Medical Supply Chain awarded a $7,738.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Concerta ER Tabs 36mg, a prescription medication used to treat attention deficit hyperactivity disorder. The contract, which is classified as a child order under a larger vehicle, carries an ultimate completion date of August 14, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This award...
- This is a $31,886.71 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CONCERTA ER TABS 36MG, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of March 17, 2025 and was awarded on March 14, 2025. This contract award is part of...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $22,925.61 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Concerta ER Tabs 36mg, a prescription medication used to treat attention deficit hyperactivity disorder. This firm fixed-price, non-set-aside contract is classified as a delivery order with an ultimate completion date of August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency's Medical Supply Chain on September 15, 2025, for the supply of Concerta ER Tabs 36mg, a prescription medication used to treat attention deficit hyperactivity disorder. The contract is valued at $13,995.51 with a firm fixed price structure and an ultimate completion date of September 16, 2025. The award was made through open competition with no set-aside designation, and the place of performance...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,961.18, is for the delivery of Concerta ER Tabs 36mg, a medication used to treat attention-deficit/hyperactivity disorder (ADHD). The contract has an ultimate completion date of May 21, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FHD20Delivery Order
This delivery order, awarded July 23, 2025, by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp, provides for the supply of Concerta ER Tabs 36mg, a prescription medication used to treat attention deficit hyperactivity disorder. The contract carries a firm fixed price ceiling value of $37,627.80 with an ultimate completion date of July 24, 2025. The award represents a competitively awarded, non-set-aside contract and is performed from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical supplies to support military healthcare programs and the Defense Health Agency. The company's extensive federal contract portfolio demonstrates its capability to meet the medical procurement needs of defense and healthcare systems through consistent, competitively awarded arrangements involving firm fixed pricing.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $37.6k | 7/23/25 |